Multiomics profiling and experiments in preclinical models revealed RAD51-IN-1 as a synergistic potentiator of anlotinib sensitivity

Journal:
Science Advances
Published:
DOI:
10.1126/sciadv.aeb0855
Affiliations:
3
Authors:
10
Go to article
Institutions Authors Share
Jiangsu Provincial People's Hospital (The First Affiliated Hospital of Nanjing Medical University), China
9.000000
 0.90
Jiangsu Province Hospital of TCM, NJUCM, China
1.000000
 0.10
Interested in Oncology and Carcinogenesis?